ConductScience.org, home

Trial · NCT00786487

Training Effects on Skeletal Muscle Fatty Acid Metabolism

NCT00786487, Not applicable, Completed, University of Minnesota; results first posted 2015-07-23

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Training Effects on Skeletal Muscle Fatty Acid Metabolism. Trials, record NCT00786487. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00786487

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Training Effects on Skeletal Muscle Fatty Acid Metabolism
NCT number
NCT00786487
Status
Completed
Phases
Not applicable
Enrollment
33 participants, actual
Lead sponsor
University of Minnesota
Conditions
Healthy Volunteers
Interventions
20% lipid infusion, glycerol
First posted
2008-11-06
Last updated
2015-07-23
Results first posted
2015-07-23

Source ClinicalTrials.gov

Registered outcomes1

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryInsulin Sensitivity as Measured by Hyperinsulinemic Euglycemic Clamp at a Single Time Point (6 Hrs) After Intralipid or Glycerol Infusionat 6 hours after starting lipid/glycerol infusionInsulin sensitivity (M value: Glucose infusion rate/kg FFM/min)measured at single time point 6 hours after initiating either intralipid or glycerol infusion)

Outcomes1

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYInsulin Sensitivity as Measured by Hyperinsulinemic Euglycemic Clamp at a Single Time Point (6 Hrs) After Intralipid or Glycerol Infusionat 6 hours after starting lipid/glycerol infusionM valueMEAN

Results by group4

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Insulin Sensitivity as Measured by Hyperinsulinemic Euglycemic Clamp at a Single Time Point (6 Hrs) After Intralipid or Glycerol InfusionLipid Trained8Standard Deviation 3M value
Insulin Sensitivity as Measured by Hyperinsulinemic Euglycemic Clamp at a Single Time Point (6 Hrs) After Intralipid or Glycerol InfusionGlycerol Trained12Standard Deviation 2M value
Insulin Sensitivity as Measured by Hyperinsulinemic Euglycemic Clamp at a Single Time Point (6 Hrs) After Intralipid or Glycerol InfusionLipid Untrained6Standard Deviation 2M value
Insulin Sensitivity as Measured by Hyperinsulinemic Euglycemic Clamp at a Single Time Point (6 Hrs) After Intralipid or Glycerol InfusionGlycerol Untrained11Standard Deviation 4M value

Participant flow12

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDLipid Trained10
Overall StudySTARTEDGlycerol Trained7
Overall StudySTARTEDLipid Untrained9
Overall StudySTARTEDGlycerol Untrained7
Overall StudyCOMPLETEDLipid Trained10
Overall StudyCOMPLETEDGlycerol Trained7
Overall StudyCOMPLETEDLipid Untrained9
Overall StudyCOMPLETEDGlycerol Untrained7
Overall StudyNOT COMPLETEDLipid Trained0
Overall StudyNOT COMPLETEDGlycerol Trained0

Adverse events4

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
othernumbnessMusculoskeletal and connective tissue disordersLipid Trained1101
othernumbnessMusculoskeletal and connective tissue disordersGlycerol Trained171
othernumbnessMusculoskeletal and connective tissue disordersLipid Untrained090
othernumbnessMusculoskeletal and connective tissue disordersGlycerol Untrained060

Adverse event totals12

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityLipid Trained
Total, all-cause mortalityGlycerol Trained
Total, all-cause mortalityLipid Untrained
Total, all-cause mortalityGlycerol Untrained
Total, other adverse eventsLipid Trained110
Total, other adverse eventsGlycerol Trained17
Total, other adverse eventsLipid Untrained09
Total, other adverse eventsGlycerol Untrained06
Total, serious adverse eventsLipid Trained010
Total, serious adverse eventsGlycerol Trained07

Papers1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed as
22639293DERIVED

Source PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT00786487

GET https://conductscience.org/api/trials/v1/NCT00786487/registered